Is PET-CT Radiation — Different From Radiotherapy?

No. A PET-CT is a diagnostic tool, not a treatment. The radioactive tracer is used to produce images of where cancer cells are active in your body — it is not aimed at your tumour and is not intended to, or capable of, destroying cancer cells. Radiotherapy is a completely separate procedure, planned and delivered on different equipment, and serves an entirely different purpose.

For most adults in your household, no specific precautions are needed. IAEA guidance suggests limiting close, prolonged contact with young children and pregnant women for a few hours after the scan, while the tracer is still active. By the following day the radioactivity has largely cleared from your body. Your imaging centre will give you written instructions — follow those, and call them if you have questions specific to your situation.

The tracer used in most PET scans decays rapidly. Within a day of the scan, the radioactivity has largely cleared through natural decay and through your kidneys and bladder. Drinking plenty of water after the scan helps your body clear it more quickly, which is why your team will usually ask you to stay well hydrated. You do not need to do anything special beyond that.

The dose from a PET-CT is set at a level designed and regulated for diagnostic use — not for treatment. ICRP and IAEA classify diagnostic imaging radiation separately from therapeutic radiation because the doses are far lower. No diagnostic test is entirely without risk at a population level, but both bodies consistently judge the clinical benefit of accurate imaging to outweigh the small risk from the scan dose. If you are having frequent scans, it is reasonable to ask your oncologist how many are planned and why each one is necessary.

They serve opposite purposes. The PET-CT tells your team exactly where the cancer is and how active it is — it is the map. Radiotherapy uses that map to aim the treatment precisely. Having both is not a duplication; it is how accurate, targeted treatment works. Many people also have a PET-CT after radiotherapy to check whether the treatment has worked, which again is a diagnostic step, not more treatment.

After external beam radiotherapy — the most common type — no. The machine produces a beam that passes through your body during treatment; it does not leave any radioactive material inside you, and you are not a source of radiation when you leave the room. If you are having brachytherapy, which places a sealed radioactive source inside or near the tumour, your team will give you specific guidance about close contact with others. Ask your team which type of radiotherapy you are receiving so you know which advice applies.

Any exposure to ionising radiation carries a very small theoretical risk, and ICRP acknowledges this. At the dose levels used in diagnostic scanning, that risk is considered very low and is consistently judged by ICRP and IAEA to be outweighed by the clinical benefit of the information the scan provides. If you are concerned about the number of scans you are having, ask your oncologist how many are planned, why each one is needed, and whether any could be replaced by an alternative that uses less or no radiation.

Nuclear medicine — which includes PET-CT and other imaging procedures — uses small amounts of radioactive substances to create images of what is happening inside your body. Radiotherapy uses high-energy radiation specifically to damage and destroy cancer cells. Some nuclear medicine treatments, such as radioiodine for thyroid cancer, use radioactive substances therapeutically rather than just for imaging, which is where the lines can seem blurry. If your team mentions a radioactive treatment, ask them to explain whether it is nuclear medicine therapy, brachytherapy, or external beam radiotherapy — each is managed differently and carries different precautions.